Beta-Lactam InfusioN Group Study (BLING III)
A Phase III Randomised Controlled Trial of Continuous Beta-lactam Infusion Compared With Intermittent Beta-lactam Dosing in Critically Ill Patients
Sponsor: Australian and New Zealand Intensive Care Society Clinical Trials Group
This NA trial investigates Sepsis and is currently completed. Australian and New Zealand Intensive Care Society Clinical Trials Group leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2023 — Jan 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Oct 2021 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — May 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Australian and New Zealand Intensive Care Society Clinical Trials Group
- National Health and Medical Research Council, Australia
- The George Institute
For direct contact, visit the study record on ClinicalTrials.gov .